UT Health San Antonio’s Brett Ginsburg selected for Wellcome Leap Untangling Addiction program
August 20, 2024
Study will evaluate biomarkers and novel treatments for alcohol use disorder Brett Ginsburg, PhD, director of the Biochemical Pharmacology Analytical Laboratory at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), wa …
Associated Press: Heart disease is rampant in parts of the rural South. Researchers are hitting the road to learn why
August 20, 2024
Vasan Ramachandran, MD, FACC, FAHA, dean of the UT School of Public Health San Antonio, was quoted in this article. Read More
UT Health San Antonio joins community back-to-school event hosted by San Antonio Spurs and Frost Bank
August 16, 2024
Offering free dental screenings, strategies to help children combat anxiety and numerous other health and wellness resources, multiple schools and programs of the University of Texas Health Science Center at San Antonio participated in the third annual …
KENS 5: Student athletes encouraged to get preventative dental screenings ahead of new school year
August 15, 2024
Scott Stafford, DDS, MBA, clinical assistant professor and interim chair of the Department of Comprehensive Dentistry, was interviewed for this news segment. Watch Now
KSAT 12: Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was interviewed for this news segment. Watch Now
WOAI-TV: Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials
August 9, 2024
This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment. Watch Now
Clinical Trials Arena: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
For Worth Star-Telegram: UT Health San Antonio study — HIV drug may be effective against Alzheimer’s disease
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
MSN.com: UT Health San Antonio study: HIV drug may be effective against Alzheimer’s disease
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
Yahoo! Finance: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More